Weesp, Netherlands

Martinus T M Tulp


Average Co-Inventor Count = 6.2

ph-index = 4

Forward Citations = 74(Granted Patents)


Location History:

  • van Houtenlaan, NL (2002)
  • Weesp, NL (2001 - 2010)

Company Filing History:


Years Active: 2001-2010

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Martinus T M Tulp: Innovator in Pharmacological Compounds

Introduction

Martinus T M Tulp is a notable inventor based in Weesp, Netherlands. He has made significant contributions to the field of pharmacology, holding a total of 10 patents. His work primarily focuses on the development of new compounds that exhibit advantageous pharmacological properties.

Latest Patents

Among his latest patents are innovative piperazine and piperidine compounds. These compounds are characterized by their unique pharmacological properties, which include a high affinity for the dopamine D receptor and the serotonin reuptake site. This makes them potentially effective in treating various conditions related to disturbances in the dopaminergic and serotonergic systems, such as anxiety disorders, depression, Parkinson's disease, and schizophrenia. Additionally, Tulp has developed a group of novel phenylpiperazine derivatives that further enhance the therapeutic potential in these areas.

Career Highlights

Throughout his career, Martinus T M Tulp has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Duphar International Research B.V. and Solvay Pharmaceuticals B.V. His work in these organizations has allowed him to advance his research and contribute to the development of innovative pharmacological solutions.

Collaborations

Tulp has collaborated with esteemed colleagues, including Cornelis G Kruse and Gerben M Visser. These partnerships have played a crucial role in enhancing the scope and impact of his research.

Conclusion

Martinus T M Tulp's contributions to pharmacology through his innovative patents and collaborations highlight his significant role in advancing medical science. His work continues to pave the way for new treatments that address critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…